AZO
55
3
AAPL
42
2
DTE
52
-2
BIIB
39
-3
AIZ
76
3
ABT
42
10
AVY
51
5
DOW
38
4
LOW
27
3
ABBV
68
2
AIG
62
12
AEE
56
11
LH
39
4
CCL
36
10
BBY
33
3
APD
54
2
BLK
29
-2
VIX
55
-2
NOV
55
2
NUE
33
3
AZO
55
3
AAPL
42
2
DTE
52
-2
BIIB
39
-3
AIZ
76
3
ABT
42
10
AVY
51
5
DOW
38
4
LOW
27
3
ABBV
68
2
AIG
62
12
AEE
56
11
LH
39
4
CCL
36
10
BBY
33
3
APD
54
2
BLK
29
-2
VIX
55
-2
NOV
55
2
NUE
33
3
Financhill
Back

Biogen Quote, Financials, Valuation and Earnings

DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon

Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
39

BIIB
Biogen

Last Price:
254.10
Seasonality Move:
16.56%

7 Day Trial

ALL ACCESS PASS

$ 7

It's Called "the Singularity"

Click here to learn how to prepare yourself for what's to come.

Biogen Price Quote

$254.10
-0.92 (-1.39%)
(Updated: September 26, 2023 at 6:12 AM ET)

Biogen Key Stats

Sell
39
Biogen (BIIB) is a Sell
Day range:
$251.85 - $257.10
52-week range:
$194.63 - $319.76
Dividend yield:
0%
P/E ratio:
12.22
P/S ratio:
3.71
P/B ratio:
2.55%
Volume:
737K
Avg. volume:
730.9K
1-year change:
28.94%
Market cap:
$36.9B
Revenue:
$10.2B
EPS:
$18.37

How Much Does Biogen Make?

  • How Much Are Biogen's Sales Annually?
    BIIB Revenues are $10.2B
  • How Much Profit Does Biogen's Make A Year?
    BIIB net income is $3B

Is Biogen Growing As A Company?

  • What Is Biogen's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.05%
  • What Is Biogen's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.44%

Biogen Stock Price Performance

  • Did Biogen Stock Go Up Last Month?
    Biogen share price went down by -3.56% last month
  • Did BIIB's Share Price Rise Over The Last Year?
    BIIB share price rose by 28.94% over the past 1 year

What Is Biogen 52-Week High & Low?

  • What Is Biogen’s 52-Week High Share Price?
    Biogen has traded as high as $319.76 over the past 52 weeks
  • What Is Biogen’s 52-Week Low Share Price?
    Biogen has traded as low as $194.63 over the past 52 weeks

Biogen Price To Free Cash Flow

  • Is Biogen Stock Overvalued?
    Biogen is trading at a price to free cash flow ratio of 32.97
  • Is Biogen Stock Undervalued?
    Biogen EV to Free Cash Flow ratio is 33.06
  • What Is Biogen’s Price Earnings Growth Ratio?
    BIIB PEG ratio is 0.45
  • Is Biogen Trading At A Premium To Earnings?
    Biogen EV to EBIT ratio is 11.09

Is It Risky To Buy Biogen?

  • How Much Debt Does Biogen Have?
    Total long term debt quarterly is $6.3B
  • How Much Cash Does Biogen Have?
    Cash and short term investments quarterly total is $6.1B
  • What Is Biogen’s Book Value Per Share?
    Book value per share is 99.91

Is Biogen Cash Flow Positive?

  • What Is BIIB Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.4B
  • What Is Biogen’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3B
  • What Is Biogen’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$175.4M

Biogen Return On Invested Capital

  • Is Management Doing A Good Job?
    BIIB return on invested capital is 13.5%
  • What Is Biogen Return On Assets?
    ROA measures how assets are converting to revenues and is 10.72%
  • What Is BIIB Return On Equity?
    ROE is a measure of profitability and is 20.09%

Biogen Earnings Date & Stock Price

  • What Is Biogen's Stock Price Today?
    A single share of BIIB can be purchased today for 255.02
  • What Is Biogen’s Stock Symbol?
    Biogen trades on the S&P500 under the ticker symbol: BIIB
  • When Is Biogen’s Next Earnings Date?
    The next quarterly earnings date for Biogen is scheduled on October 25, 2023
  • When Is BIIB's next ex-dividend date?
    Biogen's next ex-dividend date is June 18, 2020
  • How To Buy Biogen Stock?
    You can buy Biogen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Biogen Competitors

  • Who Are Biogen's Competitors?
    Below is a list of companies who compete with Biogen or are related in some way:
    • AbbVie Inc (ABBV)
    • Eli Lilly and Co (LLY)
    • Pfizer Inc (PFE)
    • Reata Pharmaceuticals Inc (RETA)
    • Sage Therapeutics Inc (SAGE)

Biogen Dividend Yield

Data Unavailable

Biogen Analyst Estimates

YoY Growth Past Surprise
EPS: -43.79% 6.9%
Revenue: -5.14% 3.95%

Analyst Recommendations

Buy Recommendations: 17
Hold Recommendations: 9
Sell Recommendations: 0
Price Target: 327.51
Upside from Last Price: 28.43%

Major Shareholders

  • How many BIIB shares are owned by institutional investors?
    185.8M BIIB shares are owned by institutional investors
  • How many BIIB shares are owned by insiders?
    2.1M BIIB shares are owned by insiders